{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:11:43Z","timestamp":1773051103167,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1124\/jpet.118.252080","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T19:35:14Z","timestamp":1541014514000},"page":"66-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-8758","authenticated-orcid":false,"given":"Gwo-Jyh","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hsin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hwei S.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.252080_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1124\/jpet.118.252080_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2337\/diabetes.52.7.1825","article-title":"Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors\/calcium-release channels","volume":"52","author":"Bidasee","year":"2003","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","article-title":"Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase","volume":"53","author":"Bidasee","year":"2004","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","article-title":"Advanced glycation end products: role in pathology of diabetic cardiomyopathy","volume":"19","author":"Bodiga","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1124\/jpet.118.252080_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.118.252080_bib6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.3487117","article-title":"Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking","volume":"232","author":"Brownlee","year":"1986","journal-title":"Science"},{"key":"10.1124\/jpet.118.252080_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.118.252080_bib8","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1111\/bph.12752","article-title":"Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart","volume":"171","author":"Chang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.252080_bib9","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.00313.2002","article-title":"Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats","volume":"283","author":"Choi","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.118.252080_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2337\/diab.41.4.552","article-title":"Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction","volume":"41","author":"Corbett","year":"1992","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diabetes.47.7.1114","article-title":"Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis","volume":"47","author":"Giardino","year":"1998","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/2211-5463.12284","article-title":"Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide","volume":"7","author":"Hegab","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1124\/jpet.118.252080_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11010-009-0074-9","article-title":"Altered gene expression may underlie prolonged duration of the QT interval and ventricular action potential in streptozotocin-induced diabetic rat heart","volume":"328","author":"Howarth","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/jpet.118.252080_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.118.252080_bib15","first-page":"H2185","article-title":"Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium","volume":"277","author":"Ishikawa","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.118.252080_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1113\/jphysiol.1993.sp019866","article-title":"Calcium and potassium currents in ventricular myocytes isolated from diabetic rats","volume":"470","author":"Jourdon","year":"1993","journal-title":"J Physiol"},{"key":"10.1124\/jpet.118.252080_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1540-8167.2006.00528.x","article-title":"What are arrhythmogenic substrates in diabetic rat atria?","volume":"17","author":"Kato","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1124\/jpet.118.252080_bib18","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.118.252080_bib19","doi-asserted-by":"crossref","first-page":"H1417","DOI":"10.1152\/ajpheart.00559.2004","article-title":"Redox regulation of Ito remodeling in diabetic rat heart","volume":"288","author":"Li","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8B","key":"10.1124\/jpet.118.252080_bib20","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","article-title":"Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy","volume":"13","author":"Ma","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.118.252080_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jps.2600751104","article-title":"Man versus beast: pharmacokinetic scaling in mammals","volume":"75","author":"Mordenti","year":"1986","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.252080_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.118.252080_bib23","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1124\/jpet.118.252080_bib24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/01.CIR.93.10.1905","article-title":"Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats","volume":"93","author":"Norton","year":"1996","journal-title":"Circulation"},{"key":"10.1124\/jpet.118.252080_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-201x.1999.00538.x","article-title":"Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes","volume":"166","author":"Pacher","year":"1999","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/jpet.118.252080_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1006\/jmcc.2002.2084","article-title":"Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes","volume":"34","author":"Petrova","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.118.252080_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/bbrc.2001.4825","article-title":"Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy","volume":"283","author":"Qin","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.118.252080_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2006.08.018","article-title":"Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats","volume":"42","author":"Shao","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.118.252080_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00210-013-0852-5","article-title":"Depressed calcium-handling proteins due to endoplasmic reticulum stress and apoptosis in the diabetic heart are attenuated by argirein","volume":"386","author":"Shi","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.118.252080_bib30","doi-asserted-by":"crossref","first-page":"H150","DOI":"10.1152\/ajpheart.00737.2016","article-title":"Hyperglycemia induces defective Ca2+ homeostasis in cardiomyocytes","volume":"312","author":"Sorrentino","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.118.252080_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/dmrr.501","article-title":"Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats","volume":"21","author":"Stadler","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1124\/jpet.118.252080_bib32","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2337\/diabetes.53.7.1841","article-title":"Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide","volume":"53","author":"Sumi","year":"2004","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03346265","article-title":"QT interval, cardiovascular risk factors and risk of death in diabetes","volume":"27","author":"Veglio","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1124\/jpet.118.252080_bib34","first-page":"H1288","article-title":"Abnormalities of K+ and Ca2+ currents in ventricular myocytes from rats with chronic diabetes","volume":"269","author":"Wang","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.118.252080_bib35","doi-asserted-by":"crossref","first-page":"H86","DOI":"10.1152\/ajpheart.00010.2012","article-title":"Conduction and refractory disorders in the diabetic atrium","volume":"303","author":"Watanabe","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.118.252080_bib36","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ahj.2012.07.027","article-title":"The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction","volume":"164","author":"Willemsen","year":"2012","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.118.252080_bib37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/bjp.2008.119","article-title":"Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes","volume":"154","author":"Wu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.252080_bib38","first-page":"50","article-title":"Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease","volume":"26","author":"Yamagishi","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1124\/jpet.118.252080_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yjmcc.2004.11.015","article-title":"Rapid stimulation causes electrical remodeling in cultured atrial myocytes","volume":"38","author":"Yang","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.118.252080_bib40","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2337\/diabetes.54.11.3082","article-title":"Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart","volume":"54","author":"Yaras","year":"2005","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-016-0577-y","article-title":"Protective role of heme oxygenase-1 in atrial remodeling","volume":"111","author":"Yeh","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.118.252080_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejphar.2015.07.045","article-title":"SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy","volume":"764","author":"Yuan","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.252080_bib43","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/db08-0140","article-title":"Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.252080_bib44","doi-asserted-by":"crossref","first-page":"H1137","DOI":"10.1152\/ajpheart.2001.281.3.H1137","article-title":"Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts","volume":"281","author":"Zhong","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.252080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T16:00:56Z","timestamp":1739980856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0022356524260122"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.252080","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.252080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}